The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
A 1-42-RAGE Interaction Disrupts Tight Junctions of the Blood-Brain Barrier Via Ca2+-Calcineurin Signaling
Open accessAbstract
The blood-brain barrier (BBB), which is formed by adherens and tight junctions (TJs) of endothelial cells, maintains homeostasis of the brain. Disrupted intracellular Ca²⁺ homeostasis and breakdown of the BBB have been implicated in the pathogenesis of Alzheimer's disease (AD). The receptor for advanced glycation end products (RAGE) is known to interact with amyloid β-peptide (Aβ) and mediate Aβ transport across the BBB, contributing to the deposition of Aβ in the brain. However, molecular mechanisms underlying Aβ-RAGE interaction-induced alterations in the BBB have not been identified. We found that Aβ₁₋₄₂ induces enhanced permeability, disruption of zonula occludin-1 (ZO-1) expression in the plasma membrane, and increased intracellular calcium and matrix metalloproteinase (MMP) secretion in cultured endothelial cells. Neutralizing antibodies against RAGE and inhibitors of calcineurin and MMPs prevented Aβ₁₋₄₂-induced changes in ZO-1, suggesting that Aβ-RAGE interactions alter TJ proteins through the Ca²⁺-calcineurin pathway. Consistent with these in vitro findings, we found disrupted microvessels near Aβ plaque-deposited areas, elevated RAGE expression, and enhanced MMP secretion in microvessels of the brains of 5XFAD mice, an animal model for AD. We have identified a potential molecular pathway underlying Aβ-RAGE interaction-induced breakage of BBB integrity. This pathway might play an important role in the pathogenesis of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 2×
“To confirm these data in animal models of AD, we used 5XFAD mice, which show massive amyloid plaque deposition with neuronal loss from 2 months old and behavioral abnormality from 6 months old (Oakley et al., 2006).”
MethodThe blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012 · cited 3×
“These results are consistent with previous reports of increased RAGE expression in the vascular system in AD brain (Yan et al., 1996).”
BackgroundResultMattson, M., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., & Rydel, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00376.1992 · Cited by 1,627
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,611
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452
Fanning, A. S., Jameson, B. J., Jesaitis, L. A., & Anderson, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29745 · Cited by 1,432 · cited 2×
“ZO-1 binds directly to a wide variety of cellular proteins (Fanning et al., 1998) and orchestrates the formation of TJ complexes.”
BackgroundShibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413 · cited 4×
“Also, the influx of A across the BBB depends on its interaction with RAGE (Mackic et al., 1998), and RAGE and LRP-1 have been proposed to stabilize A concentrations in the plasma and brain through the BBB (Shibata et al., 2000).”
BackgroundInfluentialYang, Y., Estrada, E. Y., Thompson, J. F., Liu, W., & Rosenberg, G. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600375 · Cited by 1,060
Kawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053 · cited 1×
“Indeed, increased levels of free A in plasma have been reported in AD patients as well as AD mouse models (Matsubara et al., 1999; Kawarabayashi et al., 2001).”
BackgroundDe Felice, F. G., Velasco, P. T., Lambert, M. P., Viola, K., Fernandez, S. J., Ferreira, S. T., & Klein, W. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607483200 · Cited by 882 · cited 1×
“A can bind to NMDA receptors and trigger calcium influx (De Felice et al., 2007).”
BackgroundIs Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia?
Wardlaw, J. M., Sandercock, P. A. G., Dennis, M. S., & Starr, J. (2003) · Stroke · doi:10.1161/01.str.0000058480.77236.b3 · Cited by 628
A FINE STRUCTURAL ANALYSIS OF INTERCELLULAR JUNCTIONS IN THE MOUSE LIVER
Goodenough, D. A., & Revel, J. P. (1970) · The Journal of Cell Biology · doi:10.1083/jcb.45.2.272 · Cited by 623
Ellis, R. J., Olichney, J. M., Thal, L. J., Mirra, S. S., Morris, J. C., Beekly, D., & Heyman, A. (1996) · Neurology · doi:10.1212/wnl.46.6.1592 · Cited by 561
Bond, M., Fabunmi, R. P., Baker, A. H., & Newby, A. C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01034-5 · Cited by 512
Kawahara, M., Kuroda, Y., Arispe, N., & Rojas, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14077 · Cited by 294
Brown, R. C., Morris, A. P., & O'Neil, R. G. (2007) · Brain Research · doi:10.1016/j.brainres.2006.10.083 · Cited by 291
Mackic, J. B., Stins, M., McComb, J. G., Calero, M., Ghiso, J., Kim, K. S., Yan, S. D., Stern, D., Schmidt, A. M., Frangione, B., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2029 · Cited by 242
The channel hypothesis of Alzheimer’s disease: current status
Kagan, B. L., Hirakura, Y., Azimov, R., Azimova, R., & Lin, M.-C. (2002) · Peptides · doi:10.1016/s0196-9781(02)00067-0 · Cited by 230
Claudio, L. (1995) · Acta Neuropathologica · doi:10.1007/s004010050386 · Cited by 210
Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII
Heyman, A., Fillenbaum, G. G., Welsh-Bohmer, K. A., Gearing, M., Mirra, S. S., Mohs, R. C., Peterson, B. L., & Pieper, C. F. (1998) · Neurology · doi:10.1212/wnl.51.1.159 · Cited by 206
The Blood‐Brain Barrier and Cerebrovascular Pathology in Alzheimer's Disease
KALARIA, R. N. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07821.x · Cited by 195
Immunophilins in the Nervous System
Snyder, S. H., Lai, M. M., & Burnett, P. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80538-3 · Cited by 183
Marco, S., & Skaper, S. D. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.047 · Cited by 172
Truncation and Activation of Calcineurin A by Calpain I in Alzheimer Disease Brain
Liu, F., Grundke-Iqbal, I., Iqbal, K., Oda, Y., Tomizawa, K., & Gong, C.-X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507475200 · Cited by 170
New Therapeutic Targets in the Neurovascular Pathway in Alzheimer's Disease
Zloković, B. V. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.011 · Cited by 166
Tai, L. M., Holloway, K., Male, D. K., Loughlin, J., & Romero, I. A. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00717.x · Cited by 142
Li, M., Shang, D., Zhao, W., Li, T. X., Li, B., Fang, W., Zhu, L., Man, S., & Chen, Y. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803013 · Cited by 131
RAGE regulates BACE1 and Aβ generation via NFAT1 activation in Alzheimer's disease animal model
Cho, H. J., Son, S. M., Jin, S. M., Hong, H. S., Shin, D. H., Kim, S. J., Huh, K. H., & Mook‐Jung, I. (2009) · The FASEB Journal · doi:10.1096/fj.08-126383 · Cited by 130
Self-citationLee, J., Yin, K., Hsin, I., Chen, S., Fryer, J. D., Holtzman, D. M., Hsu, C. Y., & Xu, J. (2003) · Annals of Neurology · doi:10.1002/ana.10671 · Cited by 122
Stuart, R. O., Sun, A. M., Bush, K. T., & Nigám, S. K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13636 · Cited by 111
Fillenbaum, G. G., Beekly, D. L., Edland, S. D., Hughes, J. P., Heyman, A., & van Belle, G. (1997) · PubMed · Cited by 103
Overactivation of calcineurin induced by amyloid-beta and prion proteins
Agostinho, P. M., Lopes, J. P., Velez, Z., & Oliveira, C. R. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.01.005 · Cited by 76
Gonzalez‐Velasquez, F. J., Kotarek, J. A., & Moss, M. A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05618.x · Cited by 73
Synaptic Autoregulation by Metalloproteases and γ-Secretase
Restituito, S., Khatri, L., Ninan, I., Mathews, P. M., Liu, X., Weinberg, R. J., & Ziff, E. B. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2513-11.2011 · Cited by 70
The tight-junction-specific protein ZO-l is a component of the human and rat blood-brain barriers
Watson, P. M., Anderson, J. M., Vanltallie, C. M., & Doctrow, S. R. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90708-2 · Cited by 69
García-Alloza, M., Prada, C. M., Lattarulo, C. R., Fine, S., Borrelli, L. A., Betensky, R. A., Greenberg, S. M., Frosch, M. P., & Bacskai, B. J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06096.x · Cited by 68
Simm, A., Caßelmann, C. A., Schubert, A., Hofmann, S., Reimann, A., & Silber, R. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2003.12.006 · Cited by 66
Strazielle, N., Ghersi‐Egea, J., Ghiso, J. A., Dehouck, M., Frangione, B., Patlak, C. S., Fenstermacher, J. D., & Gorevic, P. D. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.1.29 · Cited by 62
Role of NADPH Oxidase in Retinal Microvascular Permeability Increase by RAGE Activation
Warboys, C. M., Toh, H.-B., & Fraser, P. A. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2730 · Cited by 58
FK506 Reduces Amyloid Plaque Burden and Induces MMP-9 in AβPP/PS1 Double Transgenic Mice
Hong, H., Hwang, J.-Y., Son, S., Kim, Y., Moon, M., & Mook-Jung, I. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100261 · Cited by 49
Self-citationDoller, A., Akool, E., Müller, R., Gutwein, P., Kurowski, C., Pfeilschifter, J. M., & Eberhardt, W. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060568 · Cited by 30
Interactions of β‐Amyloids with the Blood–Brain Barrier
Banks, W. A., Kastin, A. J., Maness, L. M., BANKS, M. F., Shayo, M., & McLay, R. N. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48470.x · Cited by 16
(1999) · doi:10.1002/1531-8249(199904)45:4<537::aid-ana20>3.0.co;2-2
Cited by
Functional morphology of the blood–brain barrier in health and disease
Liebner, S., Dijkhuizen, R. M., Reiss, Y., Plate, K. H., Agalliu, D., & Constantin, G. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1815-1 · Cited by 872
Neutrophils promote Alzheimer's disease–like pathology and cognitive decline via LFA-1 integrin
Zenaro, E., Pietronigro, E., Bianca, V. D., Piacentino, G., Marongiu, L., Budui, S., Turano, E., Rossi, B., Angiari, S., Dusi, S., et al. (2015) · Nature Medicine · doi:10.1038/nm.3913 · Cited by 865
The blood-brain barrier in Alzheimer’s disease
Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767
“…fi ndings, cerebral capillaries were found tobedisrupted nearA β deposits together withelevatedRAGEex-pression and enhanced MMP secretion in the microvessels of 5xFAD mice, ananimal modelof ADcharacterized by massiveA β accumulation in the brain at early stages of the disease (Kook et al., 2012).”
Alzheimer’s disease: A matter of blood–brain barrier dysfunction?
Montagne, A., Zhao, Z., & Zlokovic, B. V. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171406 · Cited by 672
“…Chen et al., 2017 APPSwDI, hAPP770, K670M/N671L/ E693Q/D694N, mThy1 Albumin perivascular deposits 6 mo; not studied before 6 mo Dorsal subiculum Kruyer et al., 2015 3–6 mo 6 mo 3–6 mo Davis et al., 2004; Deane et al., 2004 Loss of LRP1 endothelial expression 4 and 6 mo Cortex, hippocampus,…”
BackgroundBlood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer’s Disease
Yamazaki, Y., & Kanekiyo, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091965 · Cited by 451
“Those transmembrane TJ proteins are connected to the actin cytoskeleton through Zonula occludens-1 (ZO-1), a member of membrane-associated guanylate kinase–like (MAGUK) protein [36,37] The deletion of ZO-1 leads to TJ disruption and the redistribution of active myosin II in vitro [38].”
BackgroundResultInfluential
Metadata
- Authors
- Kook, S.-Y., Hong, H. S., Moon, M., Ha, C. M., Chang, S., & Mook-Jung, I.
- Venue
- Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2012-06-27
- Volume
- 32
- Issue
- 26
- Pages
- 8845-8854
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2133395047
- Cited by
- 265
- References
- 45
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.